Search - tctmd.com

Displaying 921 - 940 of 1188

Sort: Relevancy | Date

Presentation TCT 2015

Stem CellBased Ablation for Ventricular Arrhythmias

Presenter: Nabil Dib, Philippe Menasché, Angel Arenal

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Amit Patel

October 15, 2015

Presentation TCT 2015

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Douglas W. Losordo

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

Presentation TCT 2015

Cell Therapy for CHF

Presenter: Henricus J. Duckers, Bernard J. Gersh, Timothy D. Henry

October 14, 2015

Presentation TCT 2015

Gene Therapy for CHF

Presenter: Henricus J. Duckers, Bernard J. Gersh, Gary L. Schaer

October 14, 2015

Presentation TCT 2015

CPulse

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde, Dimitrios Georgakopoulos

October 14, 2015

Presentation TCT 2015

Case Introduction: A Decompensated Patient With Heart Failure and Hypotension

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

Latest Innovations in ECMO and Escalation of Therapy

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde, Jonathan M. Hill

October 14, 2015

Presentation TCT 2015

Durable Ventricular Assist Devices: Current and Next-Generation Devices and Implantation Techniques

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

NuPulse iVAS - A Minimally Invasive Advanced CHF Device

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

LA to Aorta Pumping: TandemHeart

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde, Biswajit Kar

October 14, 2015

Presentation TCT 2015

Right Heart Support: Impella RP and TandemHeart

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde, Navin K. Kapur

October 14, 2015

Presentation TCT 2015

LV to Aorta Pumping: HeartMate PHP

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

Presenter: Robert O. Bonow, Ajay J. Kirtane, William T. Abraham

October 14, 2015

Presentation TCT 2015

LV to Aorta Pumping: Impella

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde, Jonathan M. Hill

October 14, 2015

Presentation TCT 2015

Key Issues for Management of Durable VAD Patients

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde, Nir Uriel

October 14, 2015

Advertisement

Stem CellBased Ablation for Ventricular Arrhythmias

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Cell Therapy for CHF

Gene Therapy for CHF

CPulse

Case Introduction: A Decompensated Patient With Heart Failure and Hypotension

Latest Innovations in ECMO and Escalation of Therapy

Durable Ventricular Assist Devices: Current and Next-Generation Devices and Implantation Techniques

NuPulse iVAS - A Minimally Invasive Advanced CHF Device

LA to Aorta Pumping: TandemHeart

Right Heart Support: Impella RP and TandemHeart

LV to Aorta Pumping: HeartMate PHP

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

LV to Aorta Pumping: Impella

Key Issues for Management of Durable VAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content